The popular eczema cream was sold nationwide at some retailers and online via Amazon.
WASHINGTON — The Food and Drug Administration is warning consumers about a nationwide recall of an eczema cream due to microbial contamination.
Pharmacal is recalling one lot of MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, sold in 6-oz tubes, after the product was found to be contaminated with Staphylococcus aureus. The use of the contaminated product could result in a range of infections, some of which could be severe or life-threatening.
The FDA said, those with weakened immune systems or compromised skin are at an increased risk of skin infections, bone and joint infections, bloodstream infections and life-threatening conditions like sepsis and septic shock. No injuries or reactions have been reported in relation to the recall.
The eczema cream was sold wholesale, at retailers and online through Amazon. It is used as a topical cream and has the product code 5106 and UPC 012277051067.
According to Tuesday’s recall alert, the impacted lot has an expiration date of November 2026 and can be identified by lot number 1024088.
Pharmacal is also notifying distributors via email about the recall and arranging for the return of the recalled products.
Consumers who have the recalled products can contact Pharmacal by phone at 800-558-6614 or email aimho@pharmacalway.com Monday through Friday from 8 a.m. to 5 p.m. CT. The FDA urges consumers who experience any problems with the products to contact their healthcare providers.